These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1989252)

  • 1. Tumor necrosis factor alpha and interleukin-1 beta in rejecting human liver grafts.
    Hoffmann MW; Wonigeit K; Steinhoff G; Behrend M; Herzbeck H; Flad HD; Pichlmayr R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1421-3. PubMed ID: 1989252
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation.
    Bathgate AJ; Lee P; Hayes PC; Simpson KJ
    Liver Transpl; 2000 Nov; 6(6):721-7. PubMed ID: 11084058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of tumour necrosis factor serum levels in organ transplantation.
    White DJ; Obers A
    Eur Cytokine Netw; 1990; 1(4):245-9. PubMed ID: 2104246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression.
    Gaweco AS; Otto G; Otto HF; Meuer S; Geisse T; Hofmann WJ
    Transplant Proc; 1995 Feb; 27(1):1152-4. PubMed ID: 7533370
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine production after liver transplantation.
    Vogel W; Tilg H; Herold M; Dietze O; Aulitzky WE; Margreiter R; Huber C
    Transplant Proc; 1990 Aug; 22(4):1854. PubMed ID: 2117812
    [No Abstract]   [Full Text] [Related]  

  • 6. Endotoxin-induced cytokine gene expression and excretion in the liver.
    Luster MI; Germolec DR; Yoshida T; Kayama F; Thompson M
    Hepatology; 1994 Feb; 19(2):480-8. PubMed ID: 8294104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal anti-tumor necrosis factor-alpha antibody suppresses rejection, but enhances infectious complications in rat liver allograft recipients.
    Shiraishi M; Shaked A; Yasunaga C; Hasuike Y; Imagawa DK; Busuttil RW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):128-9. PubMed ID: 8438250
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of tumor necrosis factor-alpha, interleukin 1beta, and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice.
    Proudman SM; Cleland LG; Mayrhofer G
    J Rheumatol; 1999 Sep; 26(9):1877-89. PubMed ID: 10493665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of cytokine-induced neutrophil chemoattractant in rat hepatic allografts during acute rejection.
    Yamaguchi Y; Ichiguchi O; Matsumura F; Akizuki E; Matsuda T; Okabe K; Yamada S; Liang J; Mori K; Ogawa M
    Hepatology; 1997 Dec; 26(6):1546-52. PubMed ID: 9397996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients.
    Khoruts A; Stahnke L; McClain CJ; Logan G; Allen JI
    Hepatology; 1991 Feb; 13(2):267-76. PubMed ID: 1995437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity.
    Scales WE; Chensue SW; Otterness I; Kunkel SL
    J Leukoc Biol; 1989 May; 45(5):416-21. PubMed ID: 2651547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of cytokine determination for screening, differentiation, and therapy monitoring of infectious and noninfectious complications after orthotopic liver transplantation.
    Kraus T; Noronha IL; Manner M; Klar E; Küppers P; Otto G
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1509-12. PubMed ID: 1824900
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular characteristics of liver allograft rejection.
    Lautenschlager I; Höckerstedt K; Ahonen J; Eklund B; Korsbäck C; Pettersson E; Salmela K; Scheinin TM; von Willebrand E; Häyry P
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2485-6. PubMed ID: 3079088
    [No Abstract]   [Full Text] [Related]  

  • 14. Taxol enhances but does not induce interleukin-1 beta and tumor necrosis factor-alpha production.
    Allen JN; Moore SA; Wewers MD
    J Lab Clin Med; 1993 Oct; 122(4):374-81. PubMed ID: 7901310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I major histocompatibility complex antigens are induced on hepatocytes in rejecting human liver grafts.
    So SK; Snover DC; Ascher NL; Platt JL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2464-5. PubMed ID: 3274539
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of tumor-associated macrophages in renal cell carcinoma.
    Ikemoto S; Yoshida N; Narita K; Wada S; Kishimoto T; Sugimura K; Nakatani T
    Oncol Rep; 2003; 10(6):1843-9. PubMed ID: 14534706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.
    Zhang Y; Doerfler M; Lee TC; Guillemin B; Rom WN
    J Clin Invest; 1993 May; 91(5):2076-83. PubMed ID: 7683696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of various lipopolysaccharides of gram-negative bacteria on the macrophage activity, oxidative metabolism, and liver microsomal activity].
    Sibiriak SV; Sergeeva SA; Khlopushina TG; Kurchatova NN; Iusupova RSh
    Biull Eksp Biol Med; 1998 Feb; 125(2):183-6. PubMed ID: 9559133
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression.
    Gaweco AS; Otto G; Otto HF; Geisse T; Hofmann WJ
    Transplant Proc; 1994 Dec; 26(6):3111-3. PubMed ID: 7527948
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients.
    Roayaie S; Sheiner PA; Emre S; Guy S; Schwartz ME; Boros P; Miller CM
    Mediators Inflamm; 2000; 9(3-4):141-6. PubMed ID: 11132770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.